Target intelligence / Profile preview

ZNF276 antisense RNA 1 (ZNF276-AS1)

Target
ZNF276-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ZNF276 antisense RNA 1 (ZNF276-AS1) is a long non-coding RNA identified at the ZNF276 gene locus and transcribed in the antisense direction. Antisense lncRNAs commonly regulate their corresponding sense genes through diverse mechanisms, such as modulating transcription, influencing RNA stability, or affecting chromatin structure. However, unlike well-characterized antisense lncRNAs (such as ZNF667-AS1), there are currently no published studies specifically describing the biological function, disease associations, or therapeutic targeting information for ZNF276-AS1. This lncRNA does not produce a protein and is not classified among typical drug targets such as receptors, enzymes, or transporters. Additional notes: - Do not confuse with ZNF276 (Zinc Finger Protein 276): ZNF276 is a protein-coding gene that acts as a transcription factor and has been implicated in breast cancer, but ZNF276-AS1 is distinct and non-coding. - There are no results indicating ZNF276-AS1 is actively considered a therapeutic target, nor are there drugs, clinical trials, or biomarker roles associated with it. - General functions and mechanisms of antisense lncRNAs in gene regulation and cancer biology can be referenced, but specifics for ZNF276-AS1 remain undetermined. If further characterization or disease association is published in the future, these attributes should be updated accordingly.

Other names
ZNF276-AS1ZNF276 Antisense RNA 1
02

Biological functions

Regulation of gene expression (via antisense mechanism; typical functions of antisense lncRNAs include modulation of transcription, RNA stability, and epigenetic regulation)
03

Disease associations

Other (no disease role directly described for ZNF276-AS1 in current mainstream resources)

Beyond the preview

Go deeper on ZNF276 antisense RNA 1 (ZNF276-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZNF276 antisense RNA 1 (ZNF276-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call